Today's signals · RSI rebound, Mean reversion
Signal details →Zentalis Pharmaceuticals last closed at $2.78 (+10.32%) on 2026-10-05. Signals today: RSI rebound, Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -1.1×. Its overall grade ranks 690 of 741 stocks in Healthcare.
About this company
Zentalis Pharmaceuticals last closed at $2.78 (+10.32%) on 2026-10-05. Signals today: RSI rebound, Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall F · 690/741
Valuation grade C+
Related stocks
- AstraZenecaCustomer
Zentalis의 파이프라인 및 공동개발/사업화 가능성이 있는 대형 제약사
- PfizerCustomer
대형 항암제 시장의 잠재적 파트너·라이선스 아웃 대상
- MerckCustomer
면역항암·항암제 분야의 주요 상업화 파트너 후보
About Zentalis Pharmaceuticals
- What technical signals does Zentalis Pharmaceuticals (ZNTL) have?
- Zentalis Pharmaceuticals current technical signals: RSI rebound, Mean reversion.
- Is Zentalis Pharmaceuticals a cup-and-handle pattern?
- No. Zentalis Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Zentalis Pharmaceuticals?
- Market cap: $200.86M. Trailing 12 months PER: -1.1×. Latest quarter PBR: 1.36×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-06 dataset
Turn what you saw on this name into a strategy
Ask Q about Zentalis Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.